SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tenchusatsu who wrote (1245260)7/8/2020 12:40:49 PM
From: THE WATSONYOUTH1 Recommendation

Recommended By
miraje

  Read Replies (2) of 1578397
 
.........just as the Hasidic doctor claimed in NY many months ago.........treatment MUST start early ........as soon as a positive test is indicated or even sooner if the symptoms are clear. This is the exact protocol now followed at Hackensack Medical Center in Bergen County NJ..........all employees are tested every day for fever..........if fever is indicated along with any other symptom, the employee is tested immediately and then sent to a clinic the same day where the hydroxychloroquine treatment is suggested to begin immediately......even before a positive test comes back. My sisters friend had this exact procedure..........if this protocol along with not sending thousands of COVID patients back into nursing homes had been followed in NY and NJ, at least 10,000 lives could have been saved........probably more.........it's no fucking wonder why the death rate in NY/NJ is what it is compared to other states................just absolutely criminal

Message 32629189
Message 32629424

finance.yahoo.com

"HCQ impressively improved survival. In contrast, the government-favored drug remdesivir has only been shown to decrease survivors' hospital stay by four days, with no demonstrable improvement in survival," notes AAPS.

.......both Comrade Fau Chi and Gottleib are up to their eyeballs with compromises concerning remdesivir

henryford.com

freep.com

Kalkanis said there's no question that the outcome of the Henry Ford study contradicts some other research.

"We fully realize that our study differs from others that are out there, but I don't think it's necessarily a point-counterpoint conflict," he said. "You have to look at the specifics of the patient population and who benefited, and that helps everybody figure out how best to use a drug and to offer hope to people."

Kalkanis explained that the Henry Ford patients were given hydroxychloroquine earlier than those in other studies. They received the drug within a day or two of hospital admission, before the patients' immune systems "launched what is called the cytokine storm, when the inflammatory process takes over," he said.

"We actually screened patients for pre-existing conditions like cardiac disease and monitored patients very closely, and also the dosing that we gave was quite different. A lot of studies gave the drug at much higher doses that had some side effects, whereas ours didn't."

Pavlich: The media's about-face on hydroxychloroquine
BY KATIE PAVLICH, OPINION CONTRIBUTOR — 07/08/20 07:20 AM EDT 527
THE VIEWS EXPRESSED BY CONTRIBUTORS ARE THEIR OWN AND NOT THE VIEW OF THE HILL

© Getty Images

When President Trump dared to suggest the decades-old malaria drug hydroxychloroquine may help patients with the coronavirus, he was accused by reporters and commentators of dangerously “playing doctor” and engaging in “happy talk” about the disease.

“A Mad Scramble to Stock Millions of Malaria Pills, Likely for Nothing,” The New York Times fretted. “The Food and Drug Administration’s abrupt decision this week to revoke an emergency waiver for two malaria drugs promoted by President Trump as potential ‘game changers’ against the coronavirus has left 66 million doses stranded in the federal stockpile — and officials do not yet know what they will do with them.”

The media even held Trump responsible for the death of a man who drank fish tank cleaner labeled “chloroquine.”

But then, examples of the prescription medication saving lives began to come in.

First, Michigan Democratic state Rep. Karen Whitsett credited the drug with saving her life. She visited the White House in April to tell her story and thanked the president for publicizing it as a potential option.

“Had you not brought this to the forefront of, the HQ, of being able to put this out here, I wouldn’t be here today to even have this conversation with you and to be able to talk about the needs of Detroit and talk about the people who really need this. And they need help,” she said.

At the time of Whitsett’s recovery, doctors around the country were also prescribing hydroxychloroquine in combination with zinc and seeing positive results for suffering patients.

Further, doctors around the world were prescribing it because it was working.

“An international poll of thousands of doctors rated the Trump-touted anti-malaria drug hydroxychloroquine the best treatment for the novel coronavirus. Of the 2,171 physicians surveyed, 37 percent rated hydroxychloroquine the ‘most effective therapy’ for combating the potentially deadly illness,” the New York Post reported in April. “The survey, conducted by the global health care polling company Sermo, also found that 23 percent of medical professionals had prescribed the drug in the U.S. — far less than other countries.”

And finally, a survey of 1,271 American doctors found the vast majority of them would prescribe the drug to a family member.

“Sixty-five percent of physicians across the United States said they would prescribe the anti-malaria drugs chloroquine or hydroxychloroquine to treat or prevent COVID-19 in a family member,” the April survey, conducted by health care firm Jackson & Coker, found. “Thirty-percent of the surveyed doctors said they would prescribe the medications to a family member prior to the onset of symptoms if they had been exposed to COVID-19,” they found. “Sixty-seven percent of surveyed physicians said they would take the medications themselves to treat COVID-19. Fifty-six percent said they would take the anti-malarial if they displayed symptoms and another 11 percent said they would take the medications if they got very sick from the virus.”

Now, a new study from the Henry Ford Health System shows the drug has in fact been effective in combatting the coronavirus, especially when used during early stages of the disease.

Bolsonaro says he's taking hydroxychloroquine after positive... Bolsonaro's COVID-19 diagnosis brings new uncertainty to Brazil

“A surprising new study found the controversial antimalarial drug hydroxychloroquine helped patients better survive in the hospital,” CNN reports. “A team at Henry Ford Health System in southeast Michigan said Thursday their study of 2,541 hospitalized patients found that those given hydroxychloroquine were much less likely to die. Dr. Marcus Zervos, division head of infectious disease for Henry Ford Health System, said 26% of those not given hydroxychloroquine died, compared to 13% of those who got the drug.” The team reviewed everyone treated in the hospital system since March.

Surprising? Not to those who have been able to see through the cloud of hysterical, anti-Trump bias and look at the facts. President Trump should be praised, not vilified, for quickly breaking down bureaucratic barriers, making the drug widely available should doctors choose to prescribe it to sick coronavirus patients.

Pavlich is the editor for Townhall.com and a Fox News contributor.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext